JMP Securities has initiated the coverage on Aura Biosciences Inc (NASDAQ: AURA) with a Market Outperform rating and a $26 risk-adjusted price target. Aura is developing a targeted virus-like drug ...
SAS has announced the release of JMP ® Genetics, JMP ® Microarray, and JMP ® Proteomics, three specialized genomics products for desktop statistical analysis of DNA, RNA and protein data. The suite of ...
Evolent Health, Inc. (NYSE:EVH) is one of the top 10 healthcare AI stocks to buy according to hedge funds. JMP Securities reaffirmed its Market Outperform rating and $13.00 price target on Evolent ...
Investing.com - Exelixis (NASDAQ:EXEL), a biotechnology company with a "GREAT" financial health rating according to InvestingPro, is expected to report second-quarter results that exceed analyst ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback